Characterization of novel VIM carbapenemase, VIM-38, and first detection of GES-5 carbapenem-hydrolyzing β-lactamases in Pseudomonas aeruginosa in Turkey

Diagnostic Microbiology and Infectious Disease

Volumn 78, Issue 3, 2014, Pages 292-294

  Iraz, Meryem ^a   Duzgun, Azer Ozad ^b   Cicek, Aysegul Copur ^c   Bonnin, Rémy A ^d   Ceylan, Aysenur ^a   Saral, Aysegul ^e   Nordmann, Patrice ^d   Sandalli, Cemal ^c  

^a BEZMIALEM VAKIF UNIVERSITY   (Turkey)

^b GUMUSHANE UNIVERSITY   (Turkey)

^c RECEP TAYYIP ERDOGAN UNIVERSITY   (Turkey)

^d BICÊTRE HOSPITAL   (France)

^e ARTVIN CORUH UNIVERSITY   (Turkey)

Author keywords

lactamase; Carbapenemase; Class 1 integron; ESBL; Pseudomonas aeruginosa

Indexed keywords

CARBAPENEMASE; CLASS 1 INTEGRON; ESBL; PSEUDOMONAS AERUGINOSA; Β-LACTAMASE;

AMINO ACID SUBSTITUTION; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEMS; CLONING, MOLECULAR; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENES, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; SEQUENCE ANALYSIS, DNA; TURKEY;

EID: 84893745009     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2013.12.003     Document Type: Article

References (25)

1. Bahar G., Mazzariol A., Koncan R., et al. Detection of VIM-5 metallo-beta-lactamase in a Pseudomonas aeruginosa clinical isolate from Turkey. J Antimicrob Chemother 2004, 54:282-283.
2. Bonnin R.A., Rotimi V.O., Al Hubail M., Gasiorowski E., Al Sweih N., Nordmann P., Poirel L. Wide dissemination of GES-type carbapenemases in Acinetobacter baumannii in Kuwait. Antimicrob Agents Chemother 2013, 57:183-188.
3. Celenza G., Pellegrini C., Caccamo M., Segatore B., Amicosante G., Perilli M. Spread of blaCTX-M-type and blaPER-2 b-lactamase genes in clinical isolates from Bolivian hospitals. J Antimicrob Chemother 2006, 57:975-978.
4. Chihara S., Okuzumi K., Yamamoto Y., Oikawa S., Hishinuma A. First case of New Delhi metallo-beta-lactamase 1-producing Escherichia coli infection in Japan. Clin Infect Dis 2011, 52:153-154.
5. Cicek A.C., Saral A., Iraz M., Ceylan A., Duzgun A.O., Peleg A.Y., Sandalli C. OXA- and GES-type b-lactamases predominate in extensively drug-resistant Acinetobacter baumannii isolates from a Turkish University Hospital. Clin Microbiol Infect 2013, 10.1111/1469-0691.12338.
6. OXA-320) of Class Db-lactamase in Proteus mirabilis. J Basic Microbiol 2013, 10.1002/jobm.201300264.
7. Cicek C.A., Saral A., Duzgun O.A., Yasar E., Cizmeci Z., Balci P.O., et al. Nationwide study of Escherichia coli producing extended-spectrum β-lactamases TEM, SHV and CTX-M in Turkey. J Antibiot 2013, 10.1038/ja.2013.72.
8. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing (M100-S23) 2013, CLSI, Wayne, PA.
9. Cornaglia G., Giamarellou H., Rossolini G.M. Metallo-β-lactamases: a last frontier for β-lactams?. Lancet Infect Dis 2011, 11:381-393.
10. Gacar G.G., Midilli K., Kolayli F., et al. Genetic and enzymatic properties of metallo-beta-lactamase VIM-5 from a clinical isolate of Enterobacter cloacae. Antimicrob Agents Chemother 2005, 49:4400-4403.
11. Gaynes R., Edwards J.R. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005, 41:848-854.
12. Jeon B.C., Jeong S.H., Bae I.K., Bong K.S., Lee K., Young D., et al. Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 β-lactamase in Korea. J Clin Microbiol 2005, 43:2241-2245.
13. Labuschagne Cde J., Weldhagen G.F., Ehlers M.M., Dove M.G. Emergence of class 1 integron-associated GES-5 and GES-5-like extended-spectrum beta-lactamases in clinical isolates of Pseudomonas aeruginosa in South Africa. Int J Antimicrob Agents 2008, 31:527-530.
14. Midilli K., Aygun G., Kuskucu M., et al. A novel metallo-β-lactamase (VIM-5) from a clinical isolate of Klebsiella pneumoniae. Proceedings of the KLIMIK Congress 2003, 275. Tavasli Matbaasi, Istanbul, Turkey. H. Eraksoy (Ed.).
15. Moubareck C., Brémont S., Conroy M.C., Courvalin P., Lambert T. GES-11, a novel integron-associated GES variant in Acinetobacter baumannii. Antimicrob Agents Chemother 2009, 58:3579-3581.
16. Nordmann P., Poirel L. Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect 2002, 8:321-331.
17. Nordmann P., Poirel L., Walsh T.R., Livermore D.M. The emerging NDM carbapenemases. Trends Microbiol 2011, 19:588-595.
18. Ozgumus O.B., Caylan R., Tosun I., Sandalli C., Aydin K., Koksal I. Molecular epidemiology of clinical Pseudomonas aeruginosa isolates carrying IMP-1 metallo-beta-lactamase gene in a university hospital in Turkey. Microb Drug Resist 2007, 13:191-198.
19. Picão R.C., Poirel L., Gales A.C., Nordmann P. Diversity of beta-lactamases produced by ceftazidime-resistant Pseudomonas aeruginosa isolates causing bloodstream infections in Brazil. Antimicrob Agents Chemother 2009, 53:3908-3913.
20. Poirel L., Bonnin R.A., Nordmann P. Genetic support and diversity of acquired extended-spectrum β-lactamases in Gram-negative rods. Infect Genet Evol 2012, 12:883-893.
21. Viedma E., Juan C., Acosta J., Zamorano L., Otero J.R., Sanz F., et al. Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum beta-lactamases GES-1 and GES-5 in Spain. Antimicrob Agents Chemother 2009, 53:4930-4933.
22. Wang C., Cai P., Chang D., Mi Z. A Pseudomonas aeruginosa isolate producing the GES-5 extended-spectrum beta-lactamase. J Antimicrob Chemother 2006, 57:1261-1262.
23. Woodford N., Ellington M.J., Coelho J.M., Turton J.F., Ward M.E., Brown S., et al. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int J Antimicrob Agent 2006, 27:351-353.
24. Xu L., Ensor V., Gossain S., Nye K., Hawkey P. Rapid and simple detection of blaCTX-M genes by multiplex PCR assay. J Med Microbiol 2005, 54:1183-1187.
25. Yakupogullari Y., Poirel L., Bernabeu S., Kizirgil A., Nordmann P. Multidrug-resistant Pseudomonas aeruginosa isolate co-expressing extended-spectrum beta-lactamase PER-1 and metallo-beta-lactamase VIM-2 from Turkey. J Antimicrob Chemother 2008, 61:221-222.